Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Blood

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1182/BLOOD-2004-08-2980PMID 15665111PMCID PMC1895021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of CD47 in Erythroid Cells and in Autoimmunity

  2004cited by this paper
• Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady‐state senescence

  2004cited by this paper
• Immune thrombocytopenic purpura

  2003cited by this paper
• The clearance mechanism of chilled blood platelets.

  2003cited by this paper
• IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.

  2003cited by this paper
• Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update.

  2003cited by this paper
• Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.

  2003cited by this paper
• Antiinflammatory Activity of IVIG Mediated through the Inhibitory FC Receptor

  2002cited by this paper
• Immune thrombocytopenic purpura.

  2002cited by this paper
• Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice.

  2002cited by this paper
• Negative Regulation of Platelet Clearance and of the Macrophage Phagocytic Response by the Transmembrane Glycoprotein SHPS-1*

  2002cited by this paper
• Signal regulation by family conspiracy

  2001cited by this paper
• Cd47 (Integrin-Associated Protein) Engagement of Dendritic Cell and Macrophage Counterreceptors Is Required to Prevent the Clearance of Donor Lymphohematopoietic Cells

  2001cited by this paper
• Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor–Mediated Phagocytosis

  2001cited by this paper
• Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.

  2001cited by this paper
• Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

  2001cited by this paper
• Immune inhibitory receptors.

  2000cited by this paper
• Constitutive Death of Platelets Leading to Scavenger Receptor-mediated Phagocytosis

  2000cited by this paper
• Role of CD47 as a marker of self on red blood cells.

  2000cited by this paper
• Integrin-associated Protein Is a Ligand for the P84 Neural Adhesion Molecule*

  1999cited by this paper
• Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47.

  1999cited by this paper
• Platelet proteins as autoantibody targets in idiopathic thrombocytopenic purpura

  1998cited by this paper
• The Murine P84 Neural Adhesion Molecule Is SHPS-1, a Member of the Phosphatase-Binding Protein Family

  1997cited by this paper
• A simple, fluorescent method to internally label platelets suitable for physiological measurements

  1997cited by this paper
• CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion.

  1997cited by this paper
• Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.

  1996cited by this paper
• Decreased Resistance to Bacterial Infection and Granulocyte Defects in IAP-Deficient Mice

  1996cited by this paper
• Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice.

  1993cited by this paper
• Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP.

  1987cited by this paper

• Highly Stable Aggregation‐Induced Emission‐Functionalized Histatin1 Coated With Platelet Vesicles for Diabetic Wound Healing

  2025cites this paper
• Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Platform for Tumor Therapy

  2025cites this paper
• CD47 is required for mesenchymal progenitor proliferation and fracture repair

  2025cites this paper
• CD169+ Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication

  2025cites this paper
• Recent Advances in Membrane-Coated Micro/Nanomotors in Biological Applications

  2025cites this paper
• Novel immunotherapy for gastric cancer: targeting the CD47–SIRPα axis

  2025influential citation
• Advanced nanotherapies for precision treatment of inflammatory lung diseases

  2025cites this paper
• Recent advances of engineering cell membranes for nanomedicine delivery across the blood–brain barrier

  2025cites this paper
• Nanoparticles for Thrombolytic Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Preclinical Studies

  2025cites this paper
• Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT.

  2025cites this paper
• The bifunctional nanomaterials of iron-chelating and antioxidant targeting the blood-brain barrier in the injured area alleviated cerebral ischemia-reperfusion injury

  2025cites this paper
• Platelet membrane decorated exosomes enhance targeting efficacy and therapeutic index to alleviate arterial restenosis

  2025cites this paper
• The surface-first paradigm: Engineering nanocarriers for infection-responsive drug delivery.

  2025cites this paper
• Advanced cell-derived drug delivery systems for pulmonary diseases: from bench to bedside

  2025cites this paper
• Synergistic effects of paclitaxel and platelet-superparamagnetic iron oxide nanoparticles for targeted chemo-hyperthermia therapy against breast cancer.

  2025cites this paper
• Methyl gallate-loaded platelet-mimetic liposome for targeted therapy of ulcerative colitis.

  2025cites this paper
• Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development

  2025cites this paper
• Curcumin-loaded milk-derived sEVs fused with platelet membrane attenuate endothelial senescence and promote spinal cord injury recovery in diabetic mice

  2025cites this paper
• CD47 is Required for Mesenchymal Progenitor Proliferation and Fracture Repair

  2024cites this paper
• Cell Membrane-Coated Nanoparticles for Dental, Oral, and Craniofacial Diseases

  2024cites this paper
• Platelet Membrane-Camouflaged Silver Metal-Organic Framework Biomimetic Nanoparticles for the Treatment of Triple-Negative Breast Cancer.

  2024cites this paper
• Advancement in triple-negative breast cancer therapeutics: A comprehensive review on the potential of cell membrane-coated nanoparticles

  2024cites this paper
• IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy

  2024cites this paper
• Thrombocytopenia Independently Leads to Changes in Monocyte Immune Function

  2024cites this paper
• Cell inspired delivery system equipped with natural membrane structures in applications for rescuing ischemic stroke.

  2024cites this paper
• Biomimetic nanosystems based on cell membranes (BNCMs) for cancer immunotherapy

  2024cites this paper
• Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease

  2024cites this paper
• Cell-membrane engineering strategies for clinic-guided design of nanomedicine.

  2024cites this paper
• CD47 is Required for Mesenchymal Progenitor Proliferation and Fracture Repair

  2024cites this paper
• Versatile tissue‐injectable hydrogels capable of the extended hydrolytic release of bioactive protein therapeutics

  2024cites this paper
• Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy

  2024cites this paper
• Engineered biomembrane-derived nanoparticles for nanoscale theranostics

  2023cites this paper
• Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression

  2023cites this paper
• Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model

  2023cites this paper
• SIRPα controls CD47-dependent platelet clearance in mice and humans

  2023cites this paper
• CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer

  2023cites this paper
• In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation

  2023cites this paper
• Engineering Platelet Membrane Imitating Nanoparticles for Targeted Therapeutic Delivery.

  2023cites this paper
• Magnetic Metal–Organic Framework-Based Nanoplatform with Platelet Membrane Coating as a Synergistic Programmed Cell Death Protein 1 Inhibitor against Hepatocellular Carcinoma

  2023cites this paper
• Thrombocytopenia Independently Leads to Monocyte Immune Dysfunction

  2023cites this paper
• Applications of injectable hemostatic materials in wound healing: principles, strategies, performance requirements, and future perspectives

  2023cites this paper
• Efferocytosis-inspired nanodrug treats sepsis by alleviating inflammation and secondary immunosuppression

  2023cites this paper
• Platelet membrane-coated alterbrassicene A nanoparticle inhibits calcification of the aortic valve by suppressing phosphorylation P65 NF-κB

  2023cites this paper
• “Live” Nanomaterials Process Biomimetic Recognition and Assembly In Vivo

  2023cites this paper
• Chimeric Peptide Engineered Bioregulator for Metastatic Tumor Immunotherapy through Macrophage Polarization and Phagocytosis Restoration.

  2023cites this paper
• Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications

  2023cites this paper
• A MD Simulation Prediction for Regulation of N-Terminal Modification on Binding of CD47 to CD172a in a Force-Dependent Manner

  2023cites this paper
• A bio-inspired nanoparticle coating for vascular healing and immunomodulatory by cGMP-PKG and NF-kappa B signaling pathways.

  2023cites this paper
• Construction of micro-nano robots: living cells and functionalized biological cell membranes

  2023cites this paper
• Maintaining sidedness and fluidity in cell membrane coatings supported on nano-particulate and planar surfaces

  2023cites this paper
• Exploring the Microfluidic Production of Biomimetic Hybrid Nanoparticles and Their Pharmaceutical Applications

  2023cites this paper
• Surface modification potentials of cell membrane-based materials for targeted therapies: a chemotherapy-focused review.

  2023cites this paper
• A ROS-responsive biomimetic nano-platform for enhanced chemo-photodynamic-immunotherapy efficacy.

  2022cites this paper
• Applications of Extracellular Vesicles in Abdominal Aortic Aneurysm

  2022cites this paper
• CD47: Beyond an immune checkpoint in cancer treatment.

  2022cites this paper
• CD47-SIRPα axis in cancer therapy: precise delivery of CD47-targeted therapeutics and design of anti-phagocytic drug delivery systems

  2022cites this paper
• Dressing blood-contacting devices with platelet membrane enables large-scale multifunctional biointerfacing

  2022cites this paper
• Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data

  2022cites this paper
• Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes

  2022cites this paper
• SIRPα - CD47 axis regulates dendritic cell-T cell interactions and TCR activation during T cell priming in spleen

  2022cites this paper
• CD47–SIRPα-targeted therapeutics: status and prospects

  2022cites this paper
• Thermo-Responsive Bioseparation Engineered for Human Leukocyte Enrichment Process Driven by Functionalized Polypropylene Bio-Separators

  2022cites this paper
• Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke

  2022cites this paper
• Biomimetic Nanotherapeutics: Employing Nanoghosts to fight Melanoma.

  2022cites this paper
• Biomimetic platelet membrane-coated Nanoparticles for targeted therapy.

  2022cites this paper
• Nanostructured particles assembled from natural building blocks for advanced therapies.

  2022cites this paper
• Targeting drugs to tumours using cell membrane-coated nanoparticles

  2022cites this paper
• Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells

  2022cites this paper
• Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy

  2022influential citation
• Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?

  2022cites this paper
• Biomimicry in nanotechnology: a comprehensive review

  2022cites this paper
• Design principles of bioinspired interfaces for biomedical applications in therapeutics and imaging

  2022cites this paper
• Red Phosphorus/P25 Nanophotosensitizers Coated with Platelet Membrane for Enhancing Cancer Cells Photodynamic Therapy

  2022cites this paper
• Leveraging Macrophages for Cancer Theranostics.

  2022cites this paper
• Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils

  2022cites this paper
• Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.

  2022cites this paper
• Targeting macrophages in hematological malignancies: recent advances and future directions

  2022cites this paper
• Cell‐Derived Vesicles for Nanoparticles' Coating: Biomimetic Approaches for Enhanced Blood Circulation and Cancer Therapy

  2022cites this paper
• Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective

  2021cites this paper
• Endothelial SIRPα signaling controls thymic progenitor homing for T cell regeneration and antitumor immunity

  2021cites this paper
• Biomembrane‐Functionalized Micromotors: Biocompatible Active Devices for Diverse Biomedical Applications

  2021cites this paper
• A Concise Review: The Role of Stem Cells in Cancer Progression and Therapy

  2021cites this paper
• Reversible thrombocytopenia during hibernation originates from storage and release of platelets in liver sinusoids

  2021cites this paper
• Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis

  2021cites this paper
• OTT_A_260391 2761..2772

  2021cites this paper
• Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies

  2021cites this paper
• Theranostics

  2021cites this paper
• Loss of myeloid cell-specific SIRPα, but not CD47, attenuates inflammation and suppresses atherosclerosis.

  2021cites this paper
• Circulating platelet count and glycans

  2021influential citation
• Uptake of platelets by cancer cells and recycling of the platelet protein CD42a

  2021cites this paper
• Cell membrane-derived vesicles for delivery of therapeutic agents

  2021cites this paper
• Macrophage phagocytosis after spinal cord injury: when friends become foes.

  2021cites this paper
• Putting the brakes on phagocytosis: “don't‐eat‐me” signaling in physiology and disease

  2021cites this paper
• Multifunctional Biomedical Materials Derived from Biological Membranes

  2021cites this paper
• Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury.

  2021cites this paper
• Platelet membrane-coated nanoparticles for targeted drug delivery and local chemo-photothermal therapy of orthotopic hepatocellular carcinoma.

  2020cites this paper
• Cell-derived biomimetic nanoparticles as a novel drug delivery system for atherosclerosis: predecessors and perspectives

  2020cites this paper
• Platelet-Mimicking Drug Delivery Nanoparticles for Enhanced Chemo-Photothermal Therapy of Breast Cancer

  2020cites this paper
• Blood group‐related antigen Ley on human platelets and its involvement in platelet aggregation via a possible interaction with CD61

  2020cites this paper
• Sensing and clearance of apoptotic cells.

  2020cites this paper